Assessment of substantia nigra echogenicity in German and Filipino populations using a portable ultrasound system

Journal of Ultrasound in Medicine

Volumn 31, Issue 2, 2012, Pages 191-196

  Go, Criscely L ^a   Frenzel, Antonia ^a   Rosales, Raymond L ^b,c   Lee, Lillian V ^d   Benecke, Reiner ^a   Dressler, Dirk ^e   Walter, Uwe ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY OF SANTO TOMAS HOSPITAL   (Philippines)

^c Metropolitan Medical Center Manila   (Philippines)

^d Philippine Children's Medical Center   (Philippines)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Asian population; Ethnicity; Substantia nigra; Third ventricle; Transcranial sonography; White population

Indexed keywords

DIAGNOSIS; ULTRASONIC IMAGING; ULTRASONOGRAPHY;

ASIAN POPULATION; ETHNICITY; SUBSTANTIA NIGRA; THIRD VENTRICLE; TRANSCRANIAL SONOGRAPHY; WHITE POPULATION;

ULTRASONIC EQUIPMENT;

ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DOPPLER ECHOGRAPHY; ECHOGRAPHY; ETHNOLOGY; FEMALE; GERMANY; HOSPITAL INFORMATION SYSTEM; HUMAN; INSTRUMENTATION; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PARKINSON DISEASE; PHILIPPINES; PROSPECTIVE STUDY; QUESTIONNAIRE; SUBSTANTIA NIGRA;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PHILIPPINES; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; SUBSTANTIA NIGRA; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84856715426     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2012.31.2.191     Document Type: Article

References (25)

1. Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. Lancet Neurol 2008;7:1044-1055.
2. Wollenweber FA, Schomburg R, Probst M, et al. Width of the third ventricle assessed by transcranial sonography can monitor brain atrophy in a time-and cost-effective manner: results from a longitudinal study on 500 subjects. Psychiatry Res 2011;191:212-216.
3. Walter U, Behnke S, Eyding J, et al. Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med Biol 2007;33:15-25. (Pubitemid 44959319)
4. Van de Loo S, Walter U, Behnke S, et al. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 2010;81:1087-1092.
5. Seidel G, Kaps M, Gerriets T, Hutzelmann A. Evaluation of the ventricular system in adults by transcranial duplex sonography. J Neuroimaging 1995;5:105-108.
6. Schminke U, Lorenz L, Kirsch M, et al. Diameter assessment of the third ventricle with transcranial sonography in patients with multiple sclerosis. J Neuroimaging 2010;20:53-57.
7. Bártová P, Skoloudík D, Ressner P, Langová K, Herzig R, Kanovský P. Correlation between substantia nigra features detected by sonography and Parkinson disease symptoms. J Ultrasound Med 2010;29:37-42.
8. Berg D, Becker G, Zeiler B, et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999;53:1026-1031. (Pubitemid 29442119)
9. Berg D, Roggendorf W, Schröder U, et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002;59:999-1005. (Pubitemid 34640761)
10. Zecca L, Berg D, Arzberger T, et al. In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord 2005;20:1278-1285. (Pubitemid 41645902)
11. Hoeppner J, Prudente-Morrissey L, Herpertz SC, Benecke R, Walter U. Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency. Eur Arch Psychiatry Clin Neurosci 2009;259:92-97.
12. Berg D, Seppi K, Behnke S, et al. Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons. Arch Neurol 2011;68:932-937.
13. Walter U. Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy. Expert Rev Neurother 2009;9:835-846
14. Huang YW, Jeng JS, Tsai CF, Chen LL, Wu RM. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease. Mov Disord 2007;22:550-555.
15. Kim JY, Kim ST, Jeon SH, Lee WY. Midbrain transcranial sonography in Korean patients with Parkinson's disease. Mov Disord 2007;22:1922-1926
16. Okawa M, Miwa H, Kajimoto Y, et al. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations. Intern Med 2007;46:1527-1531. (Pubitemid 47521048)
17. Skoloudík D, Walter U. Method and validity of transcranial sonography in movement disorders. Int Rev Neurobiol 2010;90:7-34.
18. Glaser M, Weber U, Hinrichs H, Niehaus L. Neuroimaging of midbrain structures with different phased-array ultrasound systems. Klin Neurophysiol 2006;37:165-168. (Pubitemid 44638963)
19. Hagenah J, König IR, Sperner J, et al. Life-long increase of substantia nigra hyperechogenicity in transcranial sonography. Neuroimage 2010;51:28-32.
20. Mehnert S, Reuter I, Schepp K, Maaser P, Stolz E, Kaps M. Transcranial sonography for diagnosis of Parkinson's disease. BMC Neurol 2010;10:9.
21. Walter U, Kanowski M, Kaufmann J, Grossmann A, Benecke R, Niehaus L. Contemporary ultrasound systems allow high-resolution transcranial imaging of small echogenic deep intracranial structures similarly as MRI: a phantom study. Neuroimage 2008;40:551-558.
22. Davis JW, Novotny R, Ross PD, Wasnich RD. The peak bone mass of Hawaiian, Filipino, Japanese, and white women living in Hawaii. Calcif Tissue Int 1994;55:249-252. (Pubitemid 24292338)
23. Kruger MC, Schollum LM, Kuhn-Sherlock B, et al. The effect of a fortified milk drink on vitamin D status and bone turnover in post-menopausal women from South East Asia. Bone 2010;46:759-767.
24. Pichardo S, Sin VW, Hynynen K. Multi-frequency characterization of the speed of sound and attenuation coefficient for longitudinal transmission of freshly excised human skulls. Phys Med Biol 2011;56:219-250.
25. Berg D, Hochstrasser H, Schweitzer KJ, Riess O. Disturbance of iron metabolism in Parkinson's disease: ultrasonography as a biomarker. Neurotox Res 2006;9:1-13.